🇨🇦 Adjuvant letrozole (postmenopausal women) in Canada

Adjuvant letrozole (postmenopausal women) (adjuvant-letrozole-postmenopausal-women) regulatory status in Canada.

Marketing authorisation

Adjuvant letrozole (postmenopausal women) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Canada

Frequently asked questions

Is Adjuvant letrozole (postmenopausal women) approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Adjuvant letrozole (postmenopausal women) in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.